Concepts (229)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 36 | 2022 | 3479 | 2.610 |
Why?
|
| Artifacts | 6 | 2022 | 243 | 1.450 |
Why?
|
| Head | 6 | 2022 | 131 | 1.420 |
Why?
|
| Thermography | 3 | 2021 | 13 | 1.380 |
Why?
|
| Surgery, Computer-Assisted | 4 | 2021 | 116 | 0.870 |
Why?
|
| Neck | 3 | 2022 | 98 | 0.870 |
Why?
|
| Contrast Media | 11 | 2018 | 988 | 0.810 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2022 | 2592 | 0.780 |
Why?
|
| Patient Safety | 2 | 2016 | 218 | 0.780 |
Why?
|
| Image Interpretation, Computer-Assisted | 11 | 2015 | 629 | 0.740 |
Why?
|
| Protons | 4 | 2021 | 102 | 0.720 |
Why?
|
| Prostate | 5 | 2018 | 416 | 0.710 |
Why?
|
| High-Intensity Focused Ultrasound Ablation | 2 | 2021 | 48 | 0.700 |
Why?
|
| Brain | 8 | 2020 | 2375 | 0.670 |
Why?
|
| Image Enhancement | 10 | 2016 | 505 | 0.660 |
Why?
|
| Dogs | 6 | 2018 | 634 | 0.640 |
Why?
|
| Stroke | 2 | 2020 | 1079 | 0.600 |
Why?
|
| White Matter | 1 | 2020 | 97 | 0.580 |
Why?
|
| Silicon Dioxide | 1 | 2018 | 39 | 0.570 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2021 | 293 | 0.550 |
Why?
|
| Algorithms | 10 | 2018 | 1954 | 0.530 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2017 | 15 | 0.520 |
Why?
|
| Pattern Recognition, Automated | 4 | 2011 | 217 | 0.510 |
Why?
|
| Head and Neck Neoplasms | 2 | 2021 | 1073 | 0.510 |
Why?
|
| Radiation Dosage | 3 | 2014 | 229 | 0.490 |
Why?
|
| Equipment Safety | 1 | 2016 | 31 | 0.480 |
Why?
|
| Intracranial Hemorrhages | 1 | 2017 | 135 | 0.470 |
Why?
|
| Occupational Diseases | 1 | 2016 | 53 | 0.460 |
Why?
|
| Thrombectomy | 1 | 2017 | 220 | 0.440 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2014 | 19 | 0.420 |
Why?
|
| Radiation Injuries | 1 | 2015 | 158 | 0.410 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2011 | 269 | 0.400 |
Why?
|
| Radiology | 1 | 2015 | 201 | 0.380 |
Why?
|
| Education, Medical | 1 | 2015 | 229 | 0.370 |
Why?
|
| Circle of Willis | 2 | 2011 | 5 | 0.360 |
Why?
|
| Ultrasonography | 3 | 2021 | 702 | 0.340 |
Why?
|
| Neuronavigation | 5 | 2012 | 25 | 0.340 |
Why?
|
| Axilla | 1 | 2011 | 109 | 0.340 |
Why?
|
| Phantoms, Imaging | 4 | 2019 | 484 | 0.340 |
Why?
|
| Neuroimaging | 1 | 2011 | 132 | 0.320 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2011 | 608 | 0.310 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 4 | 2015 | 299 | 0.310 |
Why?
|
| Radiometry | 1 | 2010 | 60 | 0.310 |
Why?
|
| Image Processing, Computer-Assisted | 7 | 2019 | 1262 | 0.290 |
Why?
|
| Humans | 44 | 2022 | 93615 | 0.290 |
Why?
|
| Lymph Nodes | 1 | 2011 | 548 | 0.270 |
Why?
|
| Prostatic Neoplasms | 5 | 2018 | 1775 | 0.250 |
Why?
|
| Burns | 3 | 2018 | 149 | 0.230 |
Why?
|
| Sensitivity and Specificity | 12 | 2015 | 1923 | 0.230 |
Why?
|
| Male | 21 | 2020 | 44578 | 0.230 |
Why?
|
| Reproducibility of Results | 14 | 2015 | 2718 | 0.230 |
Why?
|
| Neurosurgical Procedures | 4 | 2013 | 351 | 0.220 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2014 | 318 | 0.210 |
Why?
|
| Bandages | 2 | 2018 | 43 | 0.210 |
Why?
|
| Gadolinium | 2 | 2017 | 96 | 0.200 |
Why?
|
| Risk Factors | 3 | 2020 | 5912 | 0.190 |
Why?
|
| Gadolinium DTPA | 4 | 2013 | 233 | 0.170 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2021 | 34 | 0.170 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2021 | 49 | 0.170 |
Why?
|
| Female | 18 | 2020 | 48779 | 0.160 |
Why?
|
| Silver Compounds | 2 | 2018 | 3 | 0.160 |
Why?
|
| Africa, Western | 1 | 2020 | 12 | 0.160 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2012 | 32 | 0.160 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2021 | 180 | 0.160 |
Why?
|
| Middle Aged | 16 | 2020 | 27621 | 0.160 |
Why?
|
| Healthy Volunteers | 2 | 2017 | 148 | 0.150 |
Why?
|
| Subtraction Technique | 2 | 2012 | 125 | 0.150 |
Why?
|
| Aged | 12 | 2020 | 20469 | 0.150 |
Why?
|
| Multivariate Analysis | 2 | 2020 | 990 | 0.150 |
Why?
|
| Craniotomy | 2 | 2011 | 91 | 0.150 |
Why?
|
| Musculoskeletal Diseases | 1 | 2019 | 36 | 0.150 |
Why?
|
| Venous Thrombosis | 1 | 2021 | 257 | 0.150 |
Why?
|
| Emulsions | 1 | 2018 | 18 | 0.140 |
Why?
|
| Liver | 2 | 2019 | 1207 | 0.140 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2017 | 113 | 0.130 |
Why?
|
| Arteries | 1 | 2018 | 171 | 0.130 |
Why?
|
| Laser Therapy | 1 | 2018 | 151 | 0.120 |
Why?
|
| Cadaver | 6 | 2012 | 199 | 0.120 |
Why?
|
| Temperature | 1 | 2017 | 423 | 0.120 |
Why?
|
| Animals | 9 | 2019 | 28041 | 0.120 |
Why?
|
| Ear, Inner | 3 | 2012 | 36 | 0.120 |
Why?
|
| Prostheses and Implants | 2 | 2013 | 123 | 0.110 |
Why?
|
| Diagnosis, Differential | 2 | 2017 | 1546 | 0.110 |
Why?
|
| Safety Management | 1 | 2015 | 52 | 0.110 |
Why?
|
| Biomarkers | 1 | 2021 | 1912 | 0.110 |
Why?
|
| Artificial Intelligence | 2 | 2010 | 395 | 0.110 |
Why?
|
| Ejaculation | 1 | 2014 | 9 | 0.100 |
Why?
|
| Retrospective Studies | 4 | 2017 | 10186 | 0.100 |
Why?
|
| Equipment Failure Analysis | 2 | 2013 | 89 | 0.100 |
Why?
|
| Adult | 13 | 2017 | 27955 | 0.100 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2015 | 202 | 0.100 |
Why?
|
| Whole Body Imaging | 2 | 2010 | 40 | 0.090 |
Why?
|
| Equipment Design | 2 | 2013 | 416 | 0.090 |
Why?
|
| Body Temperature | 1 | 2013 | 131 | 0.090 |
Why?
|
| Multimodal Imaging | 1 | 2013 | 109 | 0.090 |
Why?
|
| Feasibility Studies | 2 | 2011 | 758 | 0.090 |
Why?
|
| Cranial Fossa, Middle | 1 | 2012 | 12 | 0.090 |
Why?
|
| Microvessels | 1 | 2012 | 68 | 0.090 |
Why?
|
| Liver Neoplasms | 2 | 2008 | 774 | 0.090 |
Why?
|
| Facial Nerve | 1 | 2012 | 33 | 0.090 |
Why?
|
| Breast Neoplasms | 3 | 2012 | 3158 | 0.090 |
Why?
|
| Abdominal Abscess | 1 | 2011 | 23 | 0.090 |
Why?
|
| Prostate-Specific Antigen | 1 | 2013 | 337 | 0.090 |
Why?
|
| Synovial Fluid | 1 | 2011 | 11 | 0.080 |
Why?
|
| Orbit | 1 | 2011 | 38 | 0.080 |
Why?
|
| Amides | 1 | 2011 | 54 | 0.080 |
Why?
|
| Positron-Emission Tomography | 2 | 2010 | 350 | 0.080 |
Why?
|
| Echo-Planar Imaging | 1 | 2011 | 51 | 0.080 |
Why?
|
| Curriculum | 1 | 2015 | 594 | 0.080 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2011 | 77 | 0.080 |
Why?
|
| Osteoarthritis, Knee | 1 | 2011 | 71 | 0.080 |
Why?
|
| Carcinoma, Medullary | 1 | 2010 | 9 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2012 | 353 | 0.080 |
Why?
|
| Electromagnetic Fields | 1 | 2010 | 26 | 0.080 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2012 | 291 | 0.080 |
Why?
|
| Vestibulocochlear Nerve | 1 | 2009 | 4 | 0.080 |
Why?
|
| Brain Mapping | 2 | 2011 | 570 | 0.080 |
Why?
|
| Petrous Bone | 1 | 2009 | 10 | 0.080 |
Why?
|
| Colorectal Neoplasms | 2 | 2008 | 1054 | 0.080 |
Why?
|
| Benzenesulfonates | 1 | 2010 | 49 | 0.080 |
Why?
|
| Knee Joint | 1 | 2011 | 161 | 0.080 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2009 | 23 | 0.080 |
Why?
|
| Multiple Sclerosis | 1 | 2012 | 261 | 0.080 |
Why?
|
| Silver | 1 | 2009 | 16 | 0.080 |
Why?
|
| Risk Assessment | 2 | 2014 | 2444 | 0.070 |
Why?
|
| ROC Curve | 3 | 2019 | 775 | 0.070 |
Why?
|
| Evoked Potentials | 1 | 2010 | 194 | 0.070 |
Why?
|
| United States | 3 | 2021 | 7645 | 0.070 |
Why?
|
| Pregnancy | 1 | 2016 | 3148 | 0.070 |
Why?
|
| Cerebral Arteries | 1 | 2008 | 74 | 0.070 |
Why?
|
| Infant, Newborn | 1 | 2014 | 2482 | 0.070 |
Why?
|
| Stereotaxic Techniques | 1 | 2008 | 83 | 0.070 |
Why?
|
| Temporal Bone | 1 | 2008 | 61 | 0.070 |
Why?
|
| Pyridines | 1 | 2010 | 302 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2012 | 577 | 0.070 |
Why?
|
| Tumor Microenvironment | 1 | 2011 | 554 | 0.070 |
Why?
|
| Infant | 1 | 2014 | 3222 | 0.070 |
Why?
|
| Information Storage and Retrieval | 1 | 2008 | 126 | 0.060 |
Why?
|
| Swine | 2 | 2019 | 587 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2014 | 3832 | 0.060 |
Why?
|
| Auditory Perception | 1 | 2008 | 104 | 0.060 |
Why?
|
| Endoscopy | 1 | 2009 | 366 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 603 | 0.060 |
Why?
|
| Thyroid Neoplasms | 1 | 2010 | 442 | 0.060 |
Why?
|
| Proteins | 1 | 2011 | 800 | 0.060 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2005 | 24 | 0.060 |
Why?
|
| Cognition | 1 | 2010 | 627 | 0.060 |
Why?
|
| Phospholipids | 1 | 2005 | 107 | 0.050 |
Why?
|
| Disease-Free Survival | 3 | 2014 | 1171 | 0.050 |
Why?
|
| Adolescent | 2 | 2014 | 9610 | 0.050 |
Why?
|
| Child | 1 | 2014 | 7359 | 0.050 |
Why?
|
| Aged, 80 and over | 4 | 2015 | 7073 | 0.050 |
Why?
|
| Tumor Burden | 2 | 2013 | 321 | 0.040 |
Why?
|
| Area Under Curve | 2 | 2014 | 335 | 0.040 |
Why?
|
| Reference Values | 1 | 2002 | 608 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2006 | 812 | 0.040 |
Why?
|
| Fibrinolytic Agents | 1 | 2021 | 239 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2014 | 9108 | 0.040 |
Why?
|
| Microbubbles | 1 | 2019 | 39 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2014 | 4565 | 0.040 |
Why?
|
| Pain, Procedural | 1 | 2018 | 3 | 0.040 |
Why?
|
| Pilot Projects | 2 | 2014 | 917 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2019 | 947 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2018 | 217 | 0.030 |
Why?
|
| Models, Statistical | 2 | 2011 | 585 | 0.030 |
Why?
|
| Young Adult | 3 | 2012 | 6938 | 0.030 |
Why?
|
| Microcirculation | 1 | 2014 | 98 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 884 | 0.030 |
Why?
|
| Radio Waves | 1 | 2013 | 20 | 0.020 |
Why?
|
| Biomarkers, Tumor | 2 | 2013 | 1661 | 0.020 |
Why?
|
| Biomimetics | 1 | 2013 | 28 | 0.020 |
Why?
|
| Perfusion | 1 | 2014 | 260 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2013 | 402 | 0.020 |
Why?
|
| Carotid Artery, Internal | 1 | 2012 | 69 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2011 | 186 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 302 | 0.020 |
Why?
|
| Ascites | 1 | 2011 | 54 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2011 | 87 | 0.020 |
Why?
|
| Computers | 1 | 2011 | 102 | 0.020 |
Why?
|
| Time Factors | 2 | 2010 | 5406 | 0.020 |
Why?
|
| Risk | 1 | 2012 | 657 | 0.020 |
Why?
|
| Elasticity | 1 | 2011 | 98 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2012 | 512 | 0.020 |
Why?
|
| Titanium | 1 | 2010 | 27 | 0.020 |
Why?
|
| Microsurgery | 1 | 2011 | 98 | 0.020 |
Why?
|
| Lasers | 1 | 2010 | 101 | 0.020 |
Why?
|
| Meglumine | 1 | 2010 | 36 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2010 | 23 | 0.020 |
Why?
|
| Prostatectomy | 1 | 2013 | 478 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2010 | 219 | 0.020 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2010 | 62 | 0.020 |
Why?
|
| Cerebellopontine Angle | 1 | 2009 | 10 | 0.020 |
Why?
|
| Niacinamide | 1 | 2010 | 101 | 0.020 |
Why?
|
| Observer Variation | 1 | 2011 | 571 | 0.020 |
Why?
|
| Cranial Sinuses | 1 | 2009 | 16 | 0.020 |
Why?
|
| Neuroma, Acoustic | 1 | 2009 | 19 | 0.020 |
Why?
|
| Deafness | 1 | 2009 | 47 | 0.020 |
Why?
|
| Semicircular Canals | 1 | 2009 | 29 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2010 | 97 | 0.020 |
Why?
|
| Iatrogenic Disease | 1 | 2009 | 69 | 0.020 |
Why?
|
| Skin Temperature | 1 | 2009 | 16 | 0.020 |
Why?
|
| Contraindications | 1 | 2009 | 67 | 0.020 |
Why?
|
| Individuality | 1 | 2010 | 114 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2009 | 49 | 0.020 |
Why?
|
| Automation | 1 | 2009 | 105 | 0.020 |
Why?
|
| Materials Testing | 1 | 2009 | 96 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 2010 | 139 | 0.020 |
Why?
|
| Biological Transport | 1 | 2009 | 399 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2010 | 657 | 0.020 |
Why?
|
| Injections, Intra-Arterial | 1 | 2008 | 33 | 0.020 |
Why?
|
| Discriminant Analysis | 1 | 2008 | 64 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2009 | 195 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 876 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 1449 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2009 | 407 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 456 | 0.020 |
Why?
|
| Software | 1 | 2011 | 670 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2008 | 189 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 2018 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2008 | 494 | 0.010 |
Why?
|
| Phosphorus Isotopes | 1 | 2005 | 16 | 0.010 |
Why?
|
| Survival Rate | 1 | 2009 | 1950 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1735 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2005 | 189 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 1715 | 0.010 |
Why?
|
| Prognosis | 1 | 2012 | 3913 | 0.010 |
Why?
|
| Radiographic Image Enhancement | 1 | 2006 | 449 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 2491 | 0.010 |
Why?
|
| Mutation | 1 | 2010 | 4266 | 0.010 |
Why?
|